It suggests that neither CD133 nor CXCR4 expression allows for identification of cells univocally initiating renewal of HT-29 colon cancer cells after the treatment with 5-FU, both in the absence and in the presence of vitamin D analogues. The gene discussed is PROM1; the disease is malignant colon neoplasm.